[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100580956":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":58,"collaborators":61,"id":63,"slug":18,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":18,"eligibilityCriteria":68,"healthyVolunteers":64,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":18,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":80,"overallStatus":39,"whyStopped":18,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},{"fullName":5,"class":6},"Icahn School of Medicine at Mount Sinai","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Point-of-Care Tested","EXPERIMENTAL","Participants in the intervention arm have received point-of-care testing for sexually transmitted infections.",[13],"Behavioral: Gonorrhea\u002Fchlamydia Point-of-Care Testing",{"label":15,"type":16,"description":17,"interventionNames":18},"Lab Tested","NO_INTERVENTION","Participants in the control arm have received lab-based testing for sexually transmitted infections.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","Gonorrhea\u002Fchlamydia Point-of-Care Testing","Point-of-care testing for sexually transmitted infections.",[9],[26],{"name":27,"affiliation":28,"role":29},"Sarah Wood, MD, MSHP","Mount Sinai Adolescent Health Center","PRINCIPAL_INVESTIGATOR",[31],{"name":32,"role":33,"phone":34,"phoneExt":18,"email":35},"Naomi Pressman, MS, RD","CONTACT","(212) 731-7810","naomi.pressman@mountsinai.org",[37],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Children's Hospital of Philadelphia","RECRUITING","Philadelphia","Pennsylvania","19104","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-75.16362,39.95238,{"lat":49,"lon":48},[52,56],{"name":53,"role":33,"phone":54,"phoneExt":18,"email":55},"Susan Lee, MPH","215-590-1000","lees8@chop.edu",{"name":57,"role":29,"phone":18,"phoneExt":18,"email":18},"Nadia Dowshen",{"type":29,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Sarah Wood","Associate Professor",[62],{"name":38,"class":6},"100580956",false,"NCT06844045","Point of Care STI Testing","Clinical and Implementation Outcomes of a Point of Care Sexually Transmitted Infection Testing Strategy to Improve HIV Prevention Service Delivery in Adolescents","Inclusion Criteria:\n\n\\- Patients age 16-24 years receiving POCT or lab-based GC\u002FCT testing\n\nExclusion Criteria:\n\n\\- Patients with known HIV or active PrEP prescriptions.","ALL","16 Years","24 Years",{"count":73,"type":74},6460,"ESTIMATED","INTERVENTIONAL",[77],"NA","The proposed research hypothesizes that point-of-care testing (POCT) for sexually transmitted infections (STIs) gonorrhea and chlamydia will be a feasible, acceptable, and appropriate implementation strategy for improving HIV testing and Pre-exposure prophylaxis (PrEP) delivery in youth, by increasing opportunities for clinician-patient counseling, decreasing loss to follow up, and allowing for same-day HIV prevention service provision. This hypothesis will be tested in a pragmatic non-randomized trial comparing clinical (HIV testing and PrEP counseling and prescription) and implementation (feasibility, acceptability, and appropriateness) outcomes between adolescents receiving POCT compared to laboratory-based testing at three clinics within a large pediatric health system.",[66],[81,82,83,84,85,86],"HIV Prevention","HIV Testing","HIV Pre-Exposure Prophylaxis","Gonorrhea","Chlamydia","Sexually Transmitted Infections","2026-04-29",{"date":89,"type":90},"2026-05-05","ACTUAL",{"date":92,"type":90},"2026-02-24",{"date":94,"type":74},"2026-12-31",{"name":5,"class":6},1]